Pharmafile Logo

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Photo of Jon in Cuttsy+Cuttsy branded shapes

Over the last two decades, Jon has gained extensive experience in agency commercial roles, client services, and strategy. He has worked closely with senior client stakeholders, building successful relationships, developing key accounts, creating new products, and scaling agency teams. Alongside his comprehensive healthcare experience, Jon also enriches C+C with his expertise in digital and FMCG sectors.

In 2020, Jon was honoured in the BIMA 100 list as one of the leaders, pioneers, entrepreneurs, and changemakers leading the digital sector, recognising his achievements in building and leading agency client services and project management teams.

Caroline Benson, Co-Founder, says, “Having worked with Jon over the last year, he is already a valued member of the C+C family. We are thrilled he has joined the team in a full-time capacity.”

Mathew Cutts adds, “For the last four years, we have been strengthening our leadership team in line with our growth. Jon joins us to help continue our growth plans and contribute to keeping the business aligned with ever-changing technologies, while remaining true to our ‘people first’ value.”

Jon Hume expresses, “After closely collaborating with C+C and their fantastic clients throughout most of 2023, I am privileged to take the next step and join this talented team. Their work significantly impacts patient lives every day, and I am eager to contribute.”

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

A month of insights: Key takeaways from May’s conferences

Explore key insights from some of May’s top healthcare conferences, covering patient engagement, health equity, co-creation, and tech innovation shaping clinical trials.

Cuttsy+Cuttsy and ISPEP highlight key patient insights in new clinical trials report

Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.

Motivations that matter: Understanding clinical trial participation to create better research

Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores the diverse motivations driving participation — from altruism and hope for better health to...

Cuttsy+Cuttsy welcomes new team members and celebrates a familiar face returning

Cuttsy+Cuttsy proudly announces the expansion of its team with the addition of three new hires—Michelle, Jay, and Emily—and the welcome return of former team member Sally as Account Director.

AI and away we go: key insights from Reuters Pharma 2025

AI is revolutionising the pharmaceutical industry, as highlighted at Reuters Pharma 2025, with transformative applications across marketing, drug discovery, and patient engagement, despite challenges in adoption, regulation, and data trust.

Exciting updates from our content and strategy team

Cuttsy+Cuttsy celebrates new beginnings with the appointment of Oli Bailey as Strategy Director and recognises team excellence through several well-deserved promotions.

How is generative AI transforming clinical trials?

Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis.

Content for all – how to connect with neurodiverse audiences

Discover essential strategies for crafting inclusive and accessible written content tailored for neurodivergent readers.

Cuttsy+Cuttsy launches ccura: AI powered, always human

Cuttsy+Cuttsy introduces ccura, an AI-powered healthcare communications platform that blends technology with human expertise to enhance collaboration, streamline workflows, and deliver patient-focused, high-quality solutions with security and compliance at its...

Two Sides of the Same Coin: Patient Engagement vs Patient Involvement

Unpack the difference between patient engagement and patient involvement.